| 臺大學術典藏 |
2022-02-18T06:28:59Z |
Effects of Metabolic Syndrome and Findings From Baseline Colonoscopies on Occurrence of Colorectal Neoplasms
|
Chiu H.-M.; Lee Y.-C.; Tu C.-H.; Chang L.-C.; WEN-FENG HSU; Chou C.-K.; Tsai K.-F.; Liang J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T06:28:58Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; WEN-FENG HSU; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T06:28:57Z |
Fecal Immunochemical Test Detects Sessile Serrated Adenomas and Polyps With a Low Level of Sensitivity
|
Chang L.-C.; Shun C.-T.; WEN-FENG HSU; Tu C.-H.; Tsai P.-Y.; Lin B.-R.; Liang J.-T.; Wu M.-S.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:56Z |
Adjunctive use of chromoendoscopy may improve the diagnostic performance of narrow-band imaging for small sessile serrated adenoma/polyp
|
Chang L.-C.; Tu C.-H.; Lin B.-R.; Shun C.-T.; WEN-FENG HSU; Liang J.-T.; Wang H.-P.; Wu M.-S.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:56Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; WEN-FENG HSU; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T06:28:55Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; WEN-FENG HSU; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T06:28:52Z |
Higher risk of advanced histology in adenoma less than 10 mm in fecal immunochemical test screening: Implication for management
|
WEN-FENG HSU; Cheng S.-Y.; Shun C.-T.; Chang L.-C.; Tu C.-H.; Wang H.-P.; Wu M.-S.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:52Z |
Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
|
Chen C.-C.; Luo J.-C.; Fang Y.-J.; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; WEN-FENG HSU; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; Shun C.-T.; Liu T.-Y.; Lee§ Y.-C.; Liou§ J.-M.; Wu§ M.-S.; and for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T06:28:50Z |
Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancer
|
Chang L.-C.; Shun C.-T.; Lin B.-R.; Sanduleanu S.; WEN-FENG HSU; Wu M.-S.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-14T06:28:53Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; YU-JEN FANG; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:52Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; YU-JEN FANG; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-14T06:28:51Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
YU-JEN FANG; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:51Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; YU-JEN FANG; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:50Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; YU-JEN FANG; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:49Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; YU-JEN FANG; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:48Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; YU-JEN FANG; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:47Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; YU-JEN FANG; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:45Z |
Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
|
Chen C.-C.; Luo J.-C.; YU-JEN FANG; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; Shun C.-T.; Liu T.-Y.; Lee§ Y.-C.; Liou§ J.-M.; Wu§ M.-S.; and for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T05:27:14Z |
Combination of Symptom Profile, Endoscopic Findings, and Esophageal Mucosal Histopathology Helps to Differentiate Achalasia from Refractory Gastroesophageal Reflux Disease
|
Yeh C.-C.; Shun C.-T.; Tseng L.-W.; Chiang T.-H.; Wu J.-F.; Lee H.-C.; Chen C.-C.; HSIU-PO WANG; Wu M.-S.; Tseng P.-H. |
| 臺大學術典藏 |
2022-02-08T03:50:27Z |
Androgen-induced TMPRSS2 activates matriptase and promotes extracellular matrix degradation, prostate cancer cell invasion, tumor growth, and metastasis
|
Chun-Jung Ko; Huang C.-C.; Lin H.-Y.; Juan C.-P.; Lan S.-W.; Shyu H.-Y.; Wu S.-R.; Hsiao P.-W.; Huang H.-P.; Shun C.-T.; Lee M.-S. |
| 臺大學術典藏 |
2022-01-25T07:24:22Z |
Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
|
Chen C.-C.; Luo J.-C.; Fang Y.-J.; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; Shun C.-T.; Liu T.-Y.; Lee Y.-C.; Liou J.-M.; MING-SHIANG WU; and for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-01-25T07:24:18Z |
Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study
|
Chiang T.-H.; Chen C.-C.; Tseng P.-H.; Liou J.-M.; MING-SHIANG WU; Shun C.-T.; Lee Y.-C.; Graham D.Y. |
| 臺大學術典藏 |
2022-01-25T07:24:17Z |
Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancer
|
Chang L.-C.; Shun C.-T.; Lin B.-R.; Sanduleanu S.; Hsu W.-F.; MING-SHIANG WU; Chiu H.-M. |
| 臺大學術典藏 |
2022-01-25T07:24:15Z |
Combination of Symptom Profile, Endoscopic Findings, and Esophageal Mucosal Histopathology Helps to Differentiate Achalasia from Refractory Gastroesophageal Reflux Disease
|
Yeh C.-C.; Shun C.-T.; Tseng L.-W.; Chiang T.-H.; Wu J.-F.; Lee H.-C.; Chen C.-C.; Wang H.-P.; MING-SHIANG WU; Tseng P.-H. |
| 臺大學術典藏 |
2022-01-25T05:10:35Z |
Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7
|
Hsu Y.-H.; Lin W.-L.; Hou Y.-T.; Pu Y.-S.; Shun C.-T.; CHI-LING CHEN; Wu Y.-Y.; Chen J.-Y.; Chen T.-H.; Jou T.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:08Z |
Disease progression in a patient with nonalcoholic steatohepatitis
|
Tseng P.-H.; CHUN-JEN LIU; Kao J.-H.; Shun C.-T.; Chen P.-J.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-17T08:00:28Z |
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes
|
Chen C.-H.; Dickman K.G.; Huang C.-Y.; Moriya M.; Shun C.-T.; Tai H.-C.; Huang K.-H.; Wang S.-M.; YUAN-JU LEE; Grollman A.P.; Pu Y.-S. |
| 臺大學術典藏 |
2022-01-17T08:00:24Z |
Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma
|
Chen C.-H.; Dickman K.G.; Huang C.-Y.; Shun C.-T.; Tai H.-C.; Huang K.-H.; Wang S.-M.; YUAN-JU LEE; Grollman A.P.; Pu Y.-S. |
| 臺大學術典藏 |
2022-01-10T05:34:04Z |
B-cell activating factor enhances hepatocyte-driven angiogenesis via b-cell CLL/lymphoma 10/nuclear factor-KappaB signaling during liver regeneration
|
Chou C.-H.; Ho C.-M.; SHUO-LUN LAI; Chen C.-N.; Wu Y.-M.; Shun C.-T.; Wen W.-F.; Lai H.-S. |
| 臺大學術典藏 |
2021-12-01T02:30:26Z |
Low prevalence of Helicobacter pylori but high prevalence of cytomegalovirus-associated peptic ulcer disease in AIDS patients: Comparative study of symptomatic subjects evaluated by endoscopy and CD4 counts
|
Chiu H.-M.; Wu M.-S.; CHIEN-CHING HUNG; Shun C.-T.; Lin J.-T. |
| 臺大學術典藏 |
2021-11-30T04:53:42Z |
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
|
Chou C.-H.; Hung C.-S.; Liao C.-W.; Wei L.-H.; Chen C.-W.; Shun C.-T.; Wen W.-F.; Wan C.-H.; Wu X.-M.; Chang Y.-Y.; VIN-CENT WU; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2021-11-30T04:53:14Z |
Aldosterone excess induced mitochondria decrease and dysfunction via mineralocorticoid receptor and oxidative stress in vitro and in vivo
|
Tsai C.-H.; Pan C.-T.; Chang Y.-Y.; Peng S.-Y.; Lee P.-C.; Liao C.-W.; Shun C.-T.; Li P.-T.; VIN-CENT WU; Chou C.-H.; Tsai I.-J.; Hung C.-S.; Lin Y.-H. |
| 臺大學術典藏 |
2021-11-24T08:45:24Z |
Aldosterone excess induced mitochondria decrease and dysfunction via mineralocorticoid receptor and oxidative stress in vitro and in vivo
|
CHENG-HSUAN TSAI; Pan C.-T.; Chang Y.-Y.; Peng S.-Y.; Lee P.-C.; Liao C.-W.; Shun C.-T.; Li P.-T.; Wu V.-C.; Chou C.-H.; Tsai I.-J.; Hung C.-S.; Lin Y.-H. |
| 臺大學術典藏 |
2021-11-18T04:58:23Z |
Circulating intercellular adhesion molecule 1 (ICAM-1), E-selectin and vascular cell adhesion molecule 1 (VCAM 1) in head and neck cancer
|
Liu C.-M; Sheen T.-S; JENG-YUH KO; Shun C.-T. |
| 臺大學術典藏 |
2021-11-18T04:58:20Z |
Soluble adhesion molecules and cytokines in tumor-associated tissue eosinophilia of nasopharyngeal carcinoma
|
Liu C.-M; JENG-YUH KO; Shun C.-T; Hsiao T.-Y; Sheen T.-S. |
| 臺大學術典藏 |
2021-11-18T02:47:37Z |
Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction
|
Tjiu J.-W.; Chen J.-S.; Shun C.-T.; Lin S.-J.; Liao Y.-H.; Chu C.-Y.; Tsai T.-F.; Chiu H.-C.; YANG-SHIA DAI; Inoue H.; Yang P.-C.; Kuo M.-L.; Jee S.-H. |
| 臺大學術典藏 |
2021-11-15T07:48:46Z |
Circulating intercellular adhesion molecule 1 (ICAM-1), E-selectin and vascular cell adhesion molecule 1 (VCAM 1) in head and neck cancer
|
Liu C.-M; Sheen T.-S; JENG-YUH KO; Shun C.-T. |
| 臺大學術典藏 |
2021-11-15T07:48:43Z |
Soluble adhesion molecules and cytokines in tumor-associated tissue eosinophilia of nasopharyngeal carcinoma
|
Liu C.-M; JENG-YUH KO; Shun C.-T; Hsiao T.-Y; Sheen T.-S. |
| 臺大學術典藏 |
2021-11-04T08:48:12Z |
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
|
Chou C.-H.; Hung C.-S.; CHE-WEI LIAO; Wei L.-H.; Chen C.-W.; Shun C.-T.; Wen W.-F.; Wan C.-H.; Wu X.-M.; Chang Y.-Y.; Wu V.-C.; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2021-11-04T08:48:08Z |
Aldosterone excess induced mitochondria decrease and dysfunction via mineralocorticoid receptor and oxidative stress in vitro and in vivo
|
Tsai C.-H.; Pan C.-T.; Chang Y.-Y.; Peng S.-Y.; Lee P.-C.; CHE-WEI LIAO; Shun C.-T.; Li P.-T.; Wu V.-C.; Chou C.-H.; Tsai I.-J.; Hung C.-S.; Lin Y.-H. |
| 臺大學術典藏 |
2021-10-27T03:22:25Z |
Case report: Mismatch repair proficiency and microsatellite stability in gastric cancer may not predict programmed death-1 blockade resistance
|
Chen K.-H.; CHANG-TSU YUAN; Tseng L.-H.; Shun C.-T.; Yeh K.-H. |
| 臺大學術典藏 |
2021-10-18T06:30:00Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; YEN-NIEN CHEN; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-10-18T06:29:59Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; YEN-NIEN CHEN; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-10-18T06:29:57Z |
Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands
|
Chiang T.-H.; Maeda M.; Yamada H.; Chan C.-C.; Chen S.L.-S.; Chiu S.Y.-H.; YEN-NIEN CHEN; Chou Y.-H.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; Chen H.-H.; Ushijima T.; Graham D.Y.; Lee Y.-C. |
| 臺大學術典藏 |
2021-10-14T02:46:19Z |
Primary amyloidosis of the urinary bladder
|
CHAO-YUAN HUANG; Shun C.-T.; Huang K.-H.; Chen J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:16Z |
Malignant epithelioid angiomyolipoma of the kidney.
|
Huang K.H.; CHAO-YUAN HUANG; Chung S.D.; Pu Y.S.; Shun C.T.; Chen J. |
| 臺大學術典藏 |
2021-10-14T02:46:14Z |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen C.-H.; Shun C.-T.; Huang K.-H.; CHAO-YUAN HUANG; Tsai Y.-C.; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:11Z |
Characteristics of Female Non-Muscle-Invasive Bladder Cancer in Taiwan: Association with Upper Tract Urothelial Carcinoma and End-Stage Renal Disease
|
Chen C.-H.; Shun C.-T.; Huang K.-H.; CHAO-YUAN HUANG; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-10-14T02:46:11Z |
Down-regulated expression of RhoA in human conventional renal cell carcinoma
|
Pu Y.-S.; Wang C.-W.; Liu G.-Y.; Kuo Y.-Z.; CHAO-YUAN HUANG; Kang W.-Y.; Shun C.-T.; Lin C.-C.; Wu W.-J.; Hour T.-C. |
| 臺大學術典藏 |
2021-10-14T02:46:00Z |
A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer
|
Chen C.-H.; Yang H.-J.; Shun C.-T.; CHAO-YUAN HUANG; Huang K.-H.; Yu H.-J.; Pu Y.-S. |
